Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | B Besse, BJ. Solomon, E Felip, TM Bauer, SHI Ou, RA. Soo, DR Camidge, R Chiari, SM. Gadgeel, GJ. Riely, EH Tan, H Hayashi, J Mazieres, HC. Thurm, JF Martini, A Abbattista, G Peltz, JS. Clancy, AT Shaw | ||||||||||||
Title | Lorlatinib in patients (Pts) with previously treated ALK+ advanced non-small cell lung cancer (NSCLC): Updated efficacy and safety. | ||||||||||||
|
|||||||||||||
URL | http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.9032 | ||||||||||||
Abstract Text | DOI: 10.1200/JCO.2018.36.15_suppl.9032 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|